US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cerulean Pharma

0.6550

+0.02413.82%

Volume:6.24M

Turnover:4.09M

Market Cap:19.01M

PE:-0.40

High:0.8800

Open:0.6800

Low:0.6300

Close:0.6309

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Cerulean Pharma

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Cerulean Pharma Inc., a clinical-stage company, develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. The companys lead product candidate is CRLX101, a tumor targeted nanoparticle-drug conjugate (NDC), which is in Phase 2 clinical development in patients with renal cell carcinoma; and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer. It is also developing CRLX301, a platform-generated NDC clinical candidate, which is in Phase 1/2a clinical trials. The company has a strategic collaboration with Novartis to develop nanoparticle-drug conjugates for various cancer tumor targets. The company was formerly known as Tempo Pharmaceuticals, Inc. and changed its name to Cerulean Pharma Inc. in October 2008. Cerulean Pharma Inc. was incorporated in 2005 and is based in Waltham, Massachusetts.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CERU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CERU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CERU\",,,,,undefined,":{"symbol":"CERU","market":"US","secType":"STK","nameCN":"Cerulean Pharma","latestPrice":0.655,"timestamp":1500494400000,"preClose":0.6309,"halted":4,"volume":6240590,"delay":0,"floatShares":14090000,"shares":29021000,"eps":-1.64,"marketStatus":"Delisted","change":0.0241,"latestTime":"07-19 16:00:00 EDT","open":0.68,"high":0.88,"low":0.63,"amount":4093827.04,"amplitude":0.396259,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.64,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.6309,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CERU\",,,,,undefined,":{"symbol":"CERU","floatShares":14090000,"roa":"--","roe":"--","lyrEps":0,"shares":29021000,"dividePrice":0,"high":0.88,"amplitude":0.396259,"preClose":0.6309,"low":0.63,"week52Low":0.323,"pbRate":"2.46","week52High":3.58,"institutionHeld":0,"latestPrice":0.655,"eps":-1.64,"divideRate":0,"volume":6240590,"delay":0,"ttmEps":-1.64,"open":0.68},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://","stockEarnings":[{"period":"1week","weight":-0.9501},{"period":"1month","weight":-0.9501},{"period":"3month","weight":-0.9501},{"period":"6month","weight":-0.9501},{"period":"1year","weight":-0.9501},{"period":"ytd","weight":-0.9501}],"compareEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.049},{"period":"1year","weight":0.0936},{"period":"ytd","weight":-0.0605}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cerulean Pharma Inc., a clinical-stage company, develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. The companys lead product candidate is CRLX101, a tumor targeted nanoparticle-drug conjugate (NDC), which is in Phase 2 clinical development in patients with renal cell carcinoma; and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer. It is also developing CRLX301, a platform-generated NDC clinical candidate, which is in Phase 1/2a clinical trials. The company has a strategic collaboration with Novartis to develop nanoparticle-drug conjugates for various cancer tumor targets. The company was formerly known as Tempo Pharmaceuticals, Inc. and changed its name to Cerulean Pharma Inc. in October 2008. Cerulean Pharma Inc. was incorporated in 2005 and is based in Waltham, Massachusetts.","exchange":"NASDAQ","name":"Cerulean Pharma","nameEN":"Cerulean Pharma"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CERU\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CERU\",params:#limit:5,,,undefined,":[{"date":"2017-07-20","symbol":"CERU","newSymbol":"DARE","type":"symbolChange","dateTimestamp":1500523200000},{"date":"2017-07-20","symbol":"CERU","type":"split","dateTimestamp":1500523200000,"forFactor":20,"toFactor":1},{"market":"US","date":"2017-05-12","symbol":"CERU","fiscalQuarterEnding":null,"expectedEps":-0.31,"name":null,"time":"","type":"earning","dateTimestamp":1494561600000,"reportTimeType":"","actualEps":-0.22},{"market":"US","date":"2017-03-23","symbol":"CERU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1490241600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-11-03","symbol":"CERU","fiscalQuarterEnding":null,"expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1478145600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CERU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CERU\",market:\"US\",delay:false,,,undefined,":{}}}